Ovarian Cancer Immunotherapy and Personalized Medicine

Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy. These markers include tumor mutation burden, PD-L1, tumor-infil...

Descripción completa

Detalles Bibliográficos
Autores principales: Morand, Susan, Devanaboyina, Monika, Staats, Hannah, Stanbery, Laura, Nemunaitis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234871/
https://www.ncbi.nlm.nih.gov/pubmed/34207103
http://dx.doi.org/10.3390/ijms22126532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234871/
https://www.ncbi.nlm.nih.gov/pubmed/34207103
http://dx.doi.org/10.3390/ijms22126532

Ejemplares similares